SPX-101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPX-101, covering 2019-12-30 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors [Phase 1]